- Home
- ALAR vs CGTX Comparison
ALAR vs CGTX Comparison
Compare ALAR & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- CGTX
- Stock Information
- Founded
- ALAR 2013
- CGTX 2007
- Country
- ALAR Israel
- CGTX United States
- Employees
- ALAR N/A
- CGTX N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- ALAR Technology
- CGTX Health Care
- Exchange
- ALAR Nasdaq
- CGTX Nasdaq
- Market Cap
- ALAR 45.3M
- CGTX 20.5M
- IPO Year
- ALAR 2018
- CGTX 2021
- Fundamental
- Price
- ALAR $13.89
- CGTX $0.53
- Analyst Decision
- ALAR Strong Buy
- CGTX Strong Buy
- Analyst Count
- ALAR 1
- CGTX 5
- Target Price
- ALAR $15.00
- CGTX $5.63
- AVG Volume (30 Days)
- ALAR 261.4K
- CGTX 1.9M
- Earning Date
- ALAR 08-25-2025
- CGTX 08-07-2025
- Dividend Yield
- ALAR N/A
- CGTX N/A
- EPS Growth
- ALAR N/A
- CGTX N/A
- EPS
- ALAR 0.07
- CGTX N/A
- Revenue
- ALAR $30,581,000.00
- CGTX N/A
- Revenue This Year
- ALAR N/A
- CGTX N/A
- Revenue Next Year
- ALAR $12.28
- CGTX N/A
- P/E Ratio
- ALAR $20.74
- CGTX N/A
- Revenue Growth
- ALAR 4.67
- CGTX N/A
- 52 Week Low
- ALAR $5.45
- CGTX $0.22
- 52 Week High
- ALAR $46.69
- CGTX $2.54
- Technical
- Relative Strength Index (RSI)
- ALAR 70.36
- CGTX 67.18
- Support Level
- ALAR $12.76
- CGTX $0.29
- Resistance Level
- ALAR $13.65
- CGTX $0.34
- Average True Range (ATR)
- ALAR 0.93
- CGTX 0.03
- MACD
- ALAR 0.07
- CGTX 0.01
- Stochastic Oscillator
- ALAR 86.68
- CGTX 92.26
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.